Significant progress has been made in enhancing effectiveness of chemotherapeutic agents by targeting ATR-Chk1 pathway in many cancer cells, such as colorectal cancer [36], pancreatic cancer [37], human osteosarcoma [38]. Here, CHEK1 is linked to osteosarcoma.